Financhill
Back

Akero Therapeutics Stock Predictions

Akero Therapeutics Stock Forecast

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 24% based on the past 5 years of stock performance.
  • Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Akero Therapeutics Stock Undervalued?
    The current Akero Therapeutics [AKRO] share price is $29.34. The Score for AKRO is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Akero Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Akero Therapeutics has on average historically risen by 24% based on the past 5 years of stock performance.

Akero Therapeutics Stock Rating

Sell
32
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics overpriced?

  • Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Akero Therapeutics Stock Price History

Is AKRO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com

52-Week Data

52-Week High:
37.00
52-Week Low:
15.32

Prediction Charts

Market Cap:
2B
Price in USD:
29.34
Volume:
1.6M
Beta:
-0.27

Technical Analysis

SMA50:
30.81
SMA100:
28.70
SMA200:
25.92
52-Wk Change:
36.09%

Stock Predictions

  • Is Akero Therapeutics stock public?
    Yes, Akero Therapeutics is a publicly traded company.
  • What is the Akero Therapeutics stock quote today?
    The Akero Therapeutics stock price is 29.34 USD today.
  • How to buy Akero Therapeutics stock online?
    You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 31.80 30.75 32.07 30.59
Dec-4 30.77 30.92 31.40 30.44
Dec-5 30.75 29.70 31.06 29.58
Dec-6 29.76 31.11 31.34 29.58
Dec-9 31.54 31.12 31.90 30.67
Dec-10 30.79 30.64 31.15 29.97
Dec-11 30.99 30.35 30.99 30.08
Dec-12 30.18 29.03 30.54 28.93
Dec-13 28.55 28.89 29.26 28.25
Dec-16 28.90 29.23 29.57 28.47
Dec-17 29.10 30.61 31.41 28.45
Dec-18 30.66 28.76 30.66 27.82
Dec-19 28.59 28.40 29.05 27.35
Dec-20 28.09 29.34 29.77 28.09

Akero Therapeutics Earnings

Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Akero Therapeutics Forecast Revenue Growth

Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.

* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.